EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Pig Xenotransplantation in Beta Cell Replacement: Addressing Challenges and Harnessing Potential for Type 1 Diabetes Therapy

Lorenzo Piemonti, Antonio Citro, Valentina Tomajer, Stefano Partelli, Rossana Caldara

Transplant International · 2024

DOI: 10.3389/ti.2024.13122 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Transplant International, 2024. Verfasst von Lorenzo Piemonti und 4 weiteren Autor:innen. Beteiligte Einrichtung: Clinic Unit of Regenerative Medicine and Organ Transplants and Diabetes Research Institute, Istituto di Ricovero e Cura a Carattere Scientifico (IRCC…. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 1, Transplantation, Heterologous, Islets of Langerhans Transplantation, Insulin-Secreting Cells. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 139 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This opinion paper evaluates the potential of porcine islets as a promising alternative in beta cell replacement therapy for Type 1 Diabetes (T1D), juxtaposed with the current limitations of human donor islets. It analyzes the compatibility of pig islets with human glucose metabolism, their prospects as a limitless and high-quality source of beta cells, and the unique immunogenic challenges they present in xenotransplantation. Additionally, the paper discusses the regulatory and ethical considerations pertinent to the use of porcine islets. By synthesizing current research and expert perspectives, the paper highlights both the opportunities and significant barriers that need addressing to advance pig islets as a viable therapeutic option. The findings advocate for a balanced and forward-looking approach to the integration of pig islets in T1D treatment, underscoring the need for continued research and dialogue in this evolving field.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 1Transplantation, HeterologousIslets of Langerhans TransplantationInsulin-Secreting CellsAnimalsHumansSwine

Stichwörter der Autor:innen

immunogenicityporcine isletsregulatory frameworktype 1 diabetesxenotransplantation

Autor:innen und Institutionen

  • Clinic Unit of Regenerative Medicine and Organ Transplants and Diabetes Research Institute, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Ospedale San Raffaele, Milan, Italy.
  • Diabetes Research Institute, Università Vita-Salute San Raffaele, Milan, Italy.
  • Pancreatic Surgery, Pancreas Translational and Clinical Research Center, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Ospedale San Raffaele, Milan, Italy.

Zitieren

APA

Piemonti, L., Citro, A., Tomajer, V., Partelli, S., & Caldara, R. (2024). Pig Xenotransplantation in Beta Cell Replacement: Addressing Challenges and Harnessing Potential for Type 1 Diabetes Therapy. Transplant International. https://doi.org/10.3389/ti.2024.13122

Vancouver

Piemonti L, Citro A, Tomajer V, Partelli S, Caldara R. Pig Xenotransplantation in Beta Cell Replacement: Addressing Challenges and Harnessing Potential for Type 1 Diabetes Therapy. Transplant International. 2024. doi:10.3389/ti.2024.13122

BibTeX
@article{Piemonti2024,
  author = {Piemonti, Lorenzo and Citro, Antonio and Tomajer, Valentina and Partelli, Stefano and Caldara, Rossana},
  title = {Pig Xenotransplantation in Beta Cell Replacement: Addressing Challenges and Harnessing Potential for Type 1 Diabetes Therapy},
  journal = {Transplant International},
  year = {2024},
  doi = {10.3389/ti.2024.13122}
}
Kostenlos starten →